Missing/wrong data?
Log in to edit
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
scientific article published in January 2001
Author/s
author: Doris Marko, Matthieu Garnier, Paul Greengard, Eva-Maria Mandelkow
Work details
Publication date
January 1, 2001
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.